Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Wang, Tao ^a   Han, Su Xia ^a,b   Zhang, Shang Fu ^a   Ning, Yun Ye ^a   Chen, Lei ^a   Chen, Ya Juan ^a   He, Guang Ming ^a   Xu, Dan ^a   An, Jin ^a   Yang, Ting ^a   Zhang, Xiao Hong ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CHYMASE; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA; OLIGOPEPTIDE; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INHIBITION; HAMSTER; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; MALE; MORPHOLOGY; NONHUMAN; PROTEIN SYNTHESIS; PULMONARY ARTERY REMODELING; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HYPERTROPHY; IMMUNOASSAY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SMOKING; TIME; UPREGULATION;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CHYMASES; CRICETINAE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERTENSION, PULMONARY; HYPERTROPHY; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; OLIGOPEPTIDES; PULMONARY ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMOKING; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 77954641196     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-36     Document Type: Article

References (42)

1. Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A, Ehrhart M, Oswald-Mammosser M. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:219-24.
2. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, Kim SE, Lee YS, Lee SD. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005, 172:987-93. 10.1164/rccm.200501-041OC, 16002570.
3. Wright JL, Tai H, Wang R, Wang X, Churg A. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol 2007, 292:L125-33. 10.1152/ajplung.00539.2005, 16905636.
4. Wright JL, Tai H, Churg A. Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig. J Appl Physiol 2006, 100:672-8. 10.1152/japplphysiol.00274.2005, 16210440.
5. Takai S, Jin D, Muramatsu M, Miyazaki M. Chymase as a novel target for the prevention of vascular diseases. Trends Pharmacol Sci 2004, 25:518-22. 10.1016/j.tips.2004.08.007, 15380935.
6. Takai S, Jin D, Muramatsu M, Okamoto Y, Miyazaki M. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis. Eur J Pharmacol 2004, 501:1-8. 10.1016/j.ejphar.2004.08.040, 15464056.
7. Guo C, Ju H, Leung D, Massaeli H, Shi M, Rabinovitch M. A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J Clin Invest 2001, 107:703-15. 10.1172/JCI9997, 208939, 11254670.
8. Borland JA, Kelsall C, Yacoub MH, Chester AH. Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries. Vascul Pharmacol 2005, 42:99-108. 10.1016/j.vph.2005.01.011, 15792927.
9. Miyazaki M, Takai S, Jin D, Muramatsu M. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacol Ther 2006, 112:668-76. 10.1016/j.pharmthera.2006.05.008, 16837049.
10. Kishi K, Jin D, Takai S, Muramatsu M, Katayama H, Tamai H, Miyazaki M. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats. Pediatr Res 2006, 60:77-82. 10.1203/01.pdr.0000219431.45075.d9, 16690960.
11. Zhao XY, Zhao LY, Zheng QS, Su JL, Guan H, Shang FJ, Niu XL, He YP, Lu XL. Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts. Mol Cell Biochem 2008, 310:159-66. 10.1007/s11010-007-9676-2, 18057996.
12. Kanemitsu H, Takai S, Tsuneyoshi H, Yoshikawa E, Nishina T, Miyazaki M, Ikeda T, Komeda M. Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats. Eur J Cardiothorac Surg 2008, 33:25-31. 10.1016/j.ejcts.2007.09.040, 18054245.
13. Sakaguchi M, Takai S, Jin D, Okamoto Y, Muramatsu M, Kim S, Miyazaki M. A specific chymase inhibitor, NK suppresses bleomycin-induced pulmonary fibrosis in hamsters. Eur J Pharmacol 3201, 493:173-6.
14. Tomimori Y, Muto T, Saito K, Tanaka T, Maruoka H, Sumida M, Fukami H, Fukuda Y. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice. Eur J Pharmacol 2003, 478:179-85. 10.1016/j.ejphar.2003.08.050, 14575803.
15. Zanini A, Chetta A, Saetta M, Baraldo S, D'Ippolito R, Castagnaro A, Neri M, Olivieri D. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol 2007, 120:329-33. 10.1016/j.jaci.2007.04.021, 17559912.
16. Berger P, Laurent F, Begueret H, Perot V, Rouiller R, Raherison C, Molimard M, Marthan R, Tunon-de-Lara JM. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology 2003, 228:85-94. 10.1148/radiol.2281020187, 12750458.
17. Battaglia S, Mauad T, van SAM, Vignola AM, Rabe KF, Bellia V, Sterk PJ, Hiemstra PS. Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol 2007, 60:907-11. 10.1136/jcp.2006.037002, 16917001.
18. Jin D, Takai S, Shiota N, Miyazaki M. Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens 1998, 16:657-64. 10.1097/00004872-199816050-00013, 9797177.
19. Ou XM, Wen FQ, Uhal BD, Feng YL, Huang XY, Wang T, Wang K, Liu DS, Wang X, Chen L. Simvastatin attenuates experimental small airway remodelling in rats. Respirology 2009, 14:734-45. 10.1111/j.1440-1843.2009.01549.x, 19659652.
20. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000, 6:698-702. 10.1038/76282, 10835689.
21. Huang XR, Chen WY, Truong LD, Lan HY. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 2003, 14:1738-47. 10.1097/01.ASN.0000071512.93927.4E, 12819233.
22. Chen LY, Li P, He Q, Jiang LQ, Cui CJ, Xu L, Liu LS. Transgenic study of the function of chymase in heart remodeling. J Hypertens 2002, 20:2047-55. 10.1097/00004872-200210000-00025, 12359984.
23. Shiota N, Fukamizu A, Okunishi H, Takai S, Murakami K, Miyazaki M. Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts. Biochem J 1998, 333(Pt 2):417-24. 1219600, 9657983.
24. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 2007, 369:1208-19. 10.1016/S0140-6736(07)60242-6, 17416265.
25. Kaschina E, Scholz H, Steckelings UM, Sommerfeld M, Kemnitz UR, Artuc M, Schmidt S, Unger T. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 2009, 205:396-403. 10.1016/j.atherosclerosis.2009.01.003, 19193379.
26. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 2005, 60:605-9. 10.1136/thx.2005.042994, 1747459, 15994270.
27. Perlstein TS, Lee RT. Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol 2006, 26:250-6. 10.1161/01.ATV.0000199268.27395.4f, 16339501.
28. Small-Howard A, Turner H. Exposure to tobacco-derived materials induces overproduction of secreted proteinases in mast cells. Toxicol Appl Pharmacol 2005, 204:152-63. 10.1016/j.taap.2004.09.003, 15808520.
29. Bacani C, Frishman WH. Chymase: a new pharmacologic target in cardiovascular disease. Cardiol Rev 2006, 14:187-93. 10.1097/01.crd.0000195220.62533.c5, 16788331.
30. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 1997, 272:7127-31. 10.1074/jbc.272.11.7127, 9054407.
31. Lindstedt KA, Wang Y, Shiota N, Saarinen J, Hyytiainen M, Kokkonen JO, Keski-Oja J, Kovanen PT. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J 2001, 15:1377-88. 10.1096/fj.00-0273com, 11387235.
32. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004, 125:754-65. 10.1378/chest.125.2.754, 14769761.
33. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006, 3:413-7. 10.1513/pats.200601-008AW, 2658705, 16799084.
34. Churg A, Tai H, Coulthard T, Wang R, Wright JL. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006, 174:1327-34. 10.1164/rccm.200605-585OC, 17008639.
35. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 2003, 107:2555-8. 10.1161/01.CIR.0000074041.81728.79, 12742989.
36. Kanemitsu H, Takai S, Tsuneyoshi H, Yoshikawa E, Nishina T, Miyazaki M, Ikeda T, Komeda M. Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats. Eur J Cardiothorac Surg 2008, 33:25-31. 10.1016/j.ejcts.2007.09.040, 18054245.
37. Oleksyszyn J, Powers JC. Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases. Methods Enzymol 1994, 244:423-41. full_text, 7845224.
38. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988, 106:1659-65. 10.1083/jcb.106.5.1659, 2115066, 2967299.
39. He S, Gaca MD, McEuen AR, Walls AF. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 1999, 291:517-23.
40. Takahashi H, Cease KB, Berzofsky JA. Identification of proteases that process distinct epitopes on the same protein. J Immunol 1989, 142:2221-9.
41. Richard V, Hurel-Merle S, Scalbert E, Ferry G, Lallemand F, Bessou JP, Thuillez C. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries. Circulation 2001, 104:750-2. 10.1161/hc3201.094971, 11502696.
42. D'Orleans-Juste P, Houde M, Rae GA, Bkaily G, Carrier E, Simard E. Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol 2008, 49:51-62. 10.1016/j.vph.2008.06.007, 18675382.